| __timestamp | Axsome Therapeutics, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 1392830 | 4042025 |
| Thursday, January 1, 2015 | 2419289 | 5279557 |
| Friday, January 1, 2016 | 6343648 | 8073913 |
| Sunday, January 1, 2017 | 7206691 | 44864073 |
| Monday, January 1, 2018 | 9351522 | 53488904 |
| Tuesday, January 1, 2019 | 13598030 | 65896361 |
| Wednesday, January 1, 2020 | 28896749 | 69968267 |
| Friday, January 1, 2021 | 66646205 | 92047281 |
| Saturday, January 1, 2022 | 159253661 | 131819000 |
| Sunday, January 1, 2023 | 323123000 | 87501000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, operational efficiency is key. This analysis of Selling, General, and Administrative (SG&A) expenses from 2014 to 2023 reveals intriguing trends for Pharming Group N.V. and Axsome Therapeutics, Inc. Over this period, Axsome Therapeutics saw a staggering increase in SG&A expenses, growing by over 23,000% from 2014 to 2023. This reflects their aggressive expansion and investment in marketing and administrative capabilities. In contrast, Pharming Group N.V. experienced a more modest 2,000% increase, indicating a steadier growth trajectory. Notably, in 2022, Pharming's SG&A expenses peaked at 131% of their 2014 levels, while Axsome's expenses surged to 1,592% of their 2014 levels. These figures highlight the contrasting strategies of these two companies in managing operational costs, with Axsome focusing on rapid scaling and Pharming opting for a more measured approach.
AbbVie Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Pharming Group N.V.
Comparing SG&A Expenses: Novartis AG vs Pharming Group N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Sanofi and Axsome Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Comparing SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V. Trends and Insights
Intra-Cellular Therapies, Inc. or Pharming Group N.V.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared